{"id":4511,"date":"2018-06-22T21:28:40","date_gmt":"2018-06-23T01:28:40","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=4511"},"modified":"2018-06-22T21:28:48","modified_gmt":"2018-06-23T01:28:48","slug":"ipo-pipeline-update-6-22-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-pipeline-update-6-22-18\/","title":{"rendered":"IPO Pipeline Update: 6-22-18"},"content":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.28.21-PM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-4512\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.28.21-PM.png\" alt=\"Screen Shot 2018-06-22 at 9.28.21 PM\" width=\"1120\" height=\"399\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.28.21-PM.png 1120w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.28.21-PM-600x214.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.28.21-PM-300x107.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2018\/06\/Screen-Shot-2018-06-22-at-9.28.21-PM-1024x365.png 1024w\" sizes=\"(max-width: 1120px) 100vw, 1120px\" \/><\/a><\/p>\n<p><span style=\"text-decoration: underline;\"><strong>NEW FILINGS<\/strong><\/span><\/p>\n<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 22, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline in this article.<\/p>\n<p>NEW FILINGS<\/p>\n<p>Company: Navios Maritime Containers L.P.<br \/>\nSymbol: TBD<br \/>\nDescription: They are a growth-oriented international owner and operator of containerships.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, BofA Merrill Lynch, Citigroup, Clarksons Platou Securities<br \/>\nCo-Manager(s): S. Goldman Advisors LLC<br \/>\nFiled: 6-15-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Coastal Financial Corporation<br \/>\nSymbol: CCB<br \/>\nDescription: They are a bank holding company that operates through our wholly owned subsidiary, Coastal Community Bank.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Keefe Bruyette &amp; Woods, Hovde Group<br \/>\nFiled: 6-18-18<br \/>\nListed Cash Raise: $30m<\/p>\n<p>Company: First Western Financial, Inc.<br \/>\nSymbol: MYFW<br \/>\nDescription: First Western Financial, Inc. is a financial holding company headquartered in Denver, Colorado.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Keefe Bruyette &amp; Woods, Stephens, Sandler O&#8217; Neill<br \/>\nFiled: 6-19-18<br \/>\nListed Cash Raise: $25m<\/p>\n<p>Company: Tilray, Inc.<br \/>\nSymbol: TLRY<br \/>\nDescription: They are pioneering the future of medical cannabis research, cultivation, processing and distribution globally, and we intend to become a leader in the adult-use cannabis market in Canada once legalized.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Cowen, Roth Capital, Northland Capital<br \/>\nFiled: 6-20-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Cushman &amp; Wakefield plc<br \/>\nSymbol: TBD<br \/>\nDescription: They are a top three global commercial real estate services firm with an iconic brand and approximately 48,000 employees led by an experienced executive team.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Morgan Stanley, J.P. Morgan, Goldman Sachs, UBS<br \/>\nCo-Manager(s): Barclays, BofA Merrill Lynch, Citigroup, Credit Suisse, William Blair, TPG Capital BD<br \/>\nFiled: 6-20-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Establishment Labs Holdings Inc.<br \/>\nSymbol: TBD<br \/>\nDescription: They are a medical technology company focused on improving patient safety and aesthetic outcomes, initially in the breast aesthetics and reconstruction market.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): Jefferies, Cowen, BTIG<br \/>\nFiled: 6-21-18<br \/>\nListed Cash Raise: $57.5m<\/p>\n<p>Company: Cango Inc.<br \/>\nSymbol: CANG<br \/>\nDescription: They are a leading automotive transaction service platform in China connecting dealers, financial institutions, car buyers and other industry participants.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s):Morgan Stanley, BofA Merrill Lynch, Goldman Sachs (Asia)<br \/>\nFiled: 6-22-18<br \/>\nListed Cash Raise: $300m<\/p>\n<p>Company: Allakos Inc.<br \/>\nSymbol: ALLK<br \/>\nDescription: They are are a clinical stage biotechnology company developing AK002, our wholly owned monoclonal antibody, for the treatment of various eosinophil and mast cell related diseases.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s):Goldman Sachs, Jefferies<br \/>\nCo-Manager(s): William Blair<br \/>\nFiled: 6-22-18<br \/>\nListed Cash Raise: $75m<\/p>\n<p>Company: Rubius Therapeutics, Inc.<br \/>\nSymbol: RUBY<br \/>\nDescription: They are pioneering the development of a new class of medicines, Red Cell Therapeutics, or RCTs.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s):J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners<br \/>\nFiled: 6-22-18<br \/>\nListed Cash Raise: $200m<\/p>\n<p>Company: Crinetics Pharmaceuticals, Inc.<br \/>\nSymbol: CRNX<br \/>\nDescription: They are a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Leerink Partners, Piper Jaffray<br \/>\nFiled: 6-22-18<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p>Company: Replimune Group, Inc.<br \/>\nSymbol: REPL<br \/>\nDescription: They are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets<br \/>\nFiled: 6-22-18<br \/>\nListed Cash Raise: $100m<\/p>\n<p>Company: Constellation Pharmaceuticals, Inc.<br \/>\nSymbol: CNST<br \/>\nDescription: They are a clinical-stage biopharmaceutical company using our expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with cancers associated with abnormal gene expression or drug resistance.<br \/>\nTrade Date: TBD<br \/>\nShares: TBD<br \/>\nPrice Range: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Jefferies, BMO Capital Markets<br \/>\nCo-Manager(s): Oppenheimer &amp; Co.<br \/>\nFiled: 6-22-18<br \/>\nListed Cash Raise: $86.25m<\/p>\n<p>TERMS ADDED<\/p>\n<p>Company: BJ\u2019s Wholesale Club Holdings, Inc.<br \/>\nSymbol: BJ<br \/>\nDescription: BJ\u2019s Wholesale Club is a leading warehouse club operator on the East Coast of the United States.<br \/>\nTrade Date: 6\/28<br \/>\nShares: 37.5 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): BofA Merrill Lynch, Deutsche Bank, Goldman Sachs, J.P. Morgan, Morgan Stanley, Citigroup, Jefferies, Wells Fargo<br \/>\nCo-Manager(s): Nomura, Baird, Guggenheim, Natixis, William Blair, Siebert Cisneros Shank &amp; Co.<br \/>\nTerms Added: 6-18-18<\/p>\n<p>Company: EverQuote, Inc<br \/>\nSymbol: EVER<br \/>\nDescription: They operate the largest online marketplace for insurance shopping in the United States.<br \/>\nTrade Date: 6\/28<br \/>\nShares: 4.7 million<br \/>\nPrice Range: $15.00-$17.00<br \/>\nUnderwriter(s): J.P Morgan, BofA Merrill Lynch<br \/>\nCo-Manager(s): Canaccord Genuity, JMP Securities, Needham &amp; Company Oppenheimer &amp; Co., Raymond James, William Blair<br \/>\nTerms Added: 6-18-18<\/p>\n<p>Company: Forty Seven, Inc.<br \/>\nSymbol: FTSV<br \/>\nDescription: They are a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer<br \/>\nTrade Date: 6\/28<br \/>\nShares: 6.7 million<br \/>\nPrice Range: $14.00-$16.00<br \/>\nUnderwriter(s): Morgan Stanley, Credit Suisse<br \/>\nCo-Manager(s): BTIG, Canaccord Genuity, Oppenheimer &amp; Co.<br \/>\nTerms Added: 6-18-18<\/p>\n<p>Company: Translate Bio, Inc.<br \/>\nSymbol: TBIO<br \/>\nDescription: They are a leading messenger RNA, or mRNA, therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction<br \/>\nTrade Date: 6\/28<br \/>\nShares: 7.7 million<br \/>\nPrice Range: $12.00-$14.00<br \/>\nUnderwriter(s): Citigroup, Leerink Partners, Evercore ISI<br \/>\nTerms Added; 6-18-18<\/p>\n<p>Company: BrightView Holdings, Inc.<br \/>\nSymbol: BV<br \/>\nDescription: They are the largest provider of commercial landscaping services in the United States, with revenues more than 10 times those of their next largest commercial landscaping competitor.<br \/>\nTrade Date: 6\/28<br \/>\nShares: 21.3 million<br \/>\nPrice Range: $22.00-$25.00<br \/>\nUnderwriter(s): Goldman Sachs, J.P. Morgan, KKR, UBS Investment Bank, Baird, Credit Suisse Macquarie Capital, Jefferies, Mizuho Securities, Morgan Stanley, RBC Capital Markets<br \/>\nCo-Manager(s): Nomura, Stifel, William Blair, Moelis &amp; Company, SMBC Nikko<br \/>\nTerms Added: 6-18-18<\/p>\n<p>Company: Tricida, Inc.<br \/>\nSymbol: TCDA<br \/>\nDescription: Their goal is to slow the progression of chronic kidney disease, or CKD, through the treatment of metabolic acidosis.<br \/>\nTrade Date: 6\/28<br \/>\nShares: 10.3 million<br \/>\nPrice Range: $16.00-$18.00<br \/>\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Cowen<br \/>\nTerms Added: 6-18-18<\/p>\n<p>Company: The Lovesac Company<br \/>\nSymbol: LOVE<br \/>\nDescription: They are a technology driven, omni-channel company that designs, manufactures and sells unique, high quality furniture comprised of modular couches called Sactionals and premium foam beanbag chairs called Sacs.<br \/>\nTrade Date: Week of 6\/25<br \/>\nShares: 3 million<br \/>\nPrice Range: $13.00-$15.00<br \/>\nUnderwriter(s): Roth Capital Partners<br \/>\nCo-Manager: Craig Hallum<br \/>\nTerms Added: 6-18-18<\/p>\n<p>Company: Domo, Inc.<br \/>\nSymbol: DOMO<br \/>\nDescription: Domo is an operating system that powers a business, enabling all employees to access real-time data and insights and take action from their smartphone.<br \/>\nTrade Date: 6\/29<br \/>\nShares: 9.2 million<br \/>\nPrice Range: $19.00-$22.00<br \/>\nUnderwriter(s): Morgan Stanley, Allen &amp; Company, Credit Suisse, UBS Investment Bank<br \/>\nCo-Manager(s): William Blair, JMP Securities, Cowen<br \/>\nFiled: 6-18-18<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 72 active IPOs in the pipeline as of June 15, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS IPO Boutique[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24],"tags":[],"class_list":["post-4511","post","type-post","status-publish","format-standard","hentry","category-ipo"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4511","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=4511"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4511\/revisions"}],"predecessor-version":[{"id":4514,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/4511\/revisions\/4514"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=4511"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=4511"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=4511"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}